JDRF, Lupus Research Alliance and National Multiple Sclerosis Society join forces to decode common m
(JDRF) JDRF International, the Lupus Research Alliance and the National Multiple Sclerosis Society joined forces to accelerate research and discovery in autoimmunity and are proud to announce the recipients of their first joint grants. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 24, 2021 Category: International Medicine & Public Health Source Type: news

Lupus More Deadly for Asian and Hispanic Americans: Study
TUESDAY, Feb. 23, 2021 -- More Asian and Hispanic people with lupus die prematurely than white patients, a new study reveals. Death rates in San Francisco were nearly six times higher than expected among Hispanic patients with lupus and four times... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 23, 2021 Category: General Medicine Source Type: news

Mortality Highest  for Asians, Hispanic/Latinos With Lupus
FRIDAY, Feb. 19, 2021 -- Standardized mortality ratios (SMRs) of observed-to-expected deaths are increased for patients with systemic lupus erythematosus (SLE) and are especially high for Asians and Hispanic/Latinos, according to research published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons - California, 2007-2017
This report describes mortality among minority populations with systemic lupus erythematosus. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - February 18, 2021 Category: American Health Tags: Asian American & Pacific Islander Health Hispanic health Lupus (Systemic lupus erythematosus) Minority Health MMWR Morbidity Mortality Weekly Report Mortality Data Latino Health Source Type: news

Covid-19 Vaccines And Autoimmune Disease
What are recommendations for Covid-19 vaccinations in patients with autoimmune diseases like lupus or rheumatoid arthritis? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 17, 2021 Category: Pharmaceuticals Authors: Judy Stone, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Platelets may play key role in development of lupus
(Universit é Laval) Platelets may play a key role in the development of lupus, according to a study published today by researchers at Universit é Laval and CHU de Qu é bec-Universit é Laval Research Centre. Extracellular DNA circulating in the blood of patients with lupus causes the inflammatory reaction associated with the disease. The researchers have shown that this DNA comes in part from the platelets, better known for their role in coagulating blood. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 17, 2021 Category: International Medicine & Public Health Source Type: news

Starting from the beginning may lead to better outcomes for lupus
Lupus is a chronic autoimmune disorder that causes inflammation and pain throughout the body. Most common in women (9 of 10 diagnosed cases); it attacks both joints and organs - including the skin. Lupus is not curable, but symptoms can be managed with medications. Researchers hope to learn more about lupus and identify ways to predict [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - February 16, 2021 Category: Research Source Type: news

Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus?
COVID-19 is an infectious respiratory disease caused by a coronavirus called SARS-CoV-2. If the infection becomes severe, people may need intensive care and support in hospital, including mechanical ventilation.Drugs used for other diseases were tried out in COVID-19, and this included chloroquine, used for malaria; and hydroxychloroquine used for rheumatic diseases, such as rheumatoid arthritis or systemic lupus erythematosus. The authors sought evidence of the effects of these drugs in treating people ill with the disease; in preventing the disease in people at risk of getting the disease, such as health workers; and peo...
Source: Cochrane News and Events - February 10, 2021 Category: Information Technology Authors: Katie Abbotts Source Type: news

NIH Director Francis Collins Is Fighting This Coronavirus While Preparing for the Next One
In May 2020, Dr. Francis Collins, the longtime head of the National Institutes of Health (NIH), was called to the White House to meet with Jared Kushner, the then President’s son-in-law and adviser, and Dr. Deborah Birx, the head of the White House Coronavirus Task Force. A few weeks earlier, Congress had given the NIH $1.5 billion to try to speed up the process of developing new diagnostic tests for COVID-19, and the White House, which was dubious about increasing the rate of testing, wanted to know more about what the NIH was doing. Collins is technically the boss of Dr. Anthony Fauci, but during the pandemic he ha...
Source: TIME: Health - February 4, 2021 Category: Consumer Health News Authors: Belinda Luscombe Tags: Uncategorized COVID-19 feature Magazine Source Type: news

Meta-Analysis Finds Much Less Lupus Than Expected Meta-Analysis Finds Much Less Lupus Than Expected
The prevalence of systemic lupus erythematosus appears to be much lower than previously believed and may pose'a potential risk to research funding for the disease. 'Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 2, 2021 Category: Consumer Health News Tags: Rheumatology News Source Type: news

FDA Approves Voclosporin for Lupus Nephritis FDA Approves Voclosporin for Lupus Nephritis
Lupkynis is a calcineurin-inhibitor immunosuppressant, and is the first oral medication to show effectiveness in lupus nephritis, according to the company.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 27, 2021 Category: Drugs & Pharmacology Tags: Rheumatology News Alert Source Type: news

FDA Approves Lupkynis (voclosporin) for Adult Patients with Active Lupus Nephritis
VICTORIA, British Columbia& ROCKVILLE, Md.-- January 22, 2021 -- Aurinia Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Lupkynis (voclosporin) in combination with a background... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 22, 2021 Category: Drugs & Pharmacology Source Type: news

More Than 200,000 Americans Have Lupus
A new study reveals how widespread the disease is in the United States. (Source: WebMD Health)
Source: WebMD Health - January 22, 2021 Category: Consumer Health News Source Type: news

Study Reveals New Insights into the Link Between Sunlight Exposure and Kidney Damage in Lupus
A new collaborative study from researchers at the Geisel School of Medicine at Dartmouth and the University of Washington and published in the Proceedings of the National Academy of Sciences (PNAS), reveals unexpected insights into how skin exposure to ultraviolet light can worsen clinical symptoms in autoimmune diseases such as lupus. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - January 21, 2021 Category: Hospital Management Authors: Timothy Dean Tags: News Research kidney lupus ultraviolet light Source Type: news

Study Estimates Prevalence of Lupus in the U.S.
THURSDAY, Jan. 21, 2021 -- The estimated prevalence of systemic lupus erythematosus (SLE) in the United States is 72.8/100,000, according to a study published online Jan. 21 in Arthritis& Rheumatology. Peter M. Izmirly, M.D., from the New York... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 21, 2021 Category: Pharmaceuticals Source Type: news

More Than 200,000 Americans Have Lupus
THURSDAY, Jan. 21, 2021 -- Just over 200,000 Americans have the autoimmune disorder lupus, and minority women are at highest risk, according to a new study. It's the first estimate of how widespread the disease is in the United States. The number... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 21, 2021 Category: General Medicine Source Type: news

More Than 200,000 Americans Have Lupus
Title: More Than 200,000 Americans Have LupusCategory: Health NewsCreated: 1/21/2021 12:00:00 AMLast Editorial Review: 1/21/2021 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 21, 2021 Category: Rheumatology Source Type: news

Study finds especially high rates of lupus in certain racial/ethnic groups
(Wiley) The US prevalence of the autoimmune disease lupus is 72.8 cases per 100,000 individuals, according to an analysis of population-based registries. The analysis, which is published in Arthritis& Rheumatology, found that the rate is 9 times higher for females than males (128.7 vs. 14.6 per 100,000), and it's highest among American Indians/Alaska Natives and Black females. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 21, 2021 Category: International Medicine & Public Health Source Type: news

Study pins down number of Americans with most common form of lupus
(NYU Langone Health / NYU School of Medicine) Just over 200,000 Americans suffer from systemic lupus erythematosus, or SLE, a condition in which the body's immune system mistakenly attacks its own healthy tissues, especially joints and skin, a new study shows. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 21, 2021 Category: International Medicine & Public Health Source Type: news

Study reveals new insights into the link between sunlight exposure and kidney damage
(The Geisel School of Medicine at Dartmouth) A new collaborative study from researchers at the Geisel School of Medicine at Dartmouth and the University of Washington and published in the Proceedings of the National Academy of Sciences (PNAS), reveals unexpected insights into how skin exposure to ultraviolet light can worsen clinical symptoms in autoimmune diseases such as lupus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 21, 2021 Category: International Medicine & Public Health Source Type: news

The 2018 and 2003 ISN/RPS Classification for Lupus Nephritis The 2018 and 2003 ISN/RPS Classification for Lupus Nephritis
How does the 2018 revised ISN/RPS classification for lupus nephritis differ from that of the 2003 classification?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 18, 2021 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

In lab study, nanoparticle shows promising results for treating severe allergies
For about 1 in 13 children in the U.S., usually harmless foodstuffs such as milk, eggs and peanuts can send the body ’s natural defenses into overdrive.Symptoms of food allergies can vary widely, but at worst, a systemwide allergic response can lead to anaphylaxis, a life-threatening condition characterized by a sudden drop in blood pressure and difficulty breathing.Although there are now some preventive measures for food-induced anaphylaxis, there are not yet any long-lasting solutions — treatments capable of locking the immune system into a state of tolerance, so that it doesn’t respond to allergens.Now...
Source: UCLA Newsroom: Health Sciences - January 14, 2021 Category: Universities & Medical Training Source Type: news

Hydroxychloroquine Level Tied to Thrombosis Risk in Lupus
Rate of thrombotic events lower for patients with mean HCQ blood levels>1,068 versus
Source: The Doctors Lounge - Oncology - January 11, 2021 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Oncology, Pathology, Pharmacy, Rheumatology, Journal, Source Type: news

Hydroxychloroquine Level Tied to Thrombosis Risk in Lupus
MONDAY, Jan. 11, 2021 -- For patients with systemic lupus erythematosus (SLE), lower hydroxychloroquine (HCQ) blood levels are associated with a higher risk for thrombotic events, according to a study published online Jan. 5 in Arthritis&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2021 Category: Pharmaceuticals Source Type: news

Vitamin B12 deficiency symptoms: Lupus increases your risk of tiredness - what is it?
VITAMIN B12 deficiency can lead to weakness, tiredness, lightheadedness and gastrointestinal issues. Sourced from animal products and fortified foods, your body could still be struggling to get enough if you have lupus. (Source: Daily Express - Health)
Source: Daily Express - Health - January 10, 2021 Category: Consumer Health News Source Type: news

High HCQ Blood Level May Lower Thrombosis Risk in Lupus High HCQ Blood Level May Lower Thrombosis Risk in Lupus
Studies suggest that it may protect against thrombosis, but the optimal dosing for this purpose remains unknown, wrote Michelle Petri, MD, of Johns Hopkins University, Baltimore, and colleagues.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - January 7, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Two-Thirds of Lupus Patients Likely to Take COVID-19 Vaccine
WEDNESDAY, Jan. 6, 2021 -- Two-thirds of people with lupus are willing to receive a COVID-19 vaccine, according to the results of a survey released by the Lupus Research Alliance. The Lupus Research Alliance conducted an online survey between Oct.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 6, 2021 Category: Pharmaceuticals Source Type: news

Hematologic Indices as Predictive Parameters for SLE Hematologic Indices as Predictive Parameters for SLE
This study investigated whether hematologic indices such as NLR, PLR, MPV, PDW, and RDW might serve as markers of disease activity in systemic lupus erythematosus.Laboratory Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 6, 2021 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Hydroxychloroquine blood levels predict clotting risk in patients with lupus
(Wiley) A new study in Arthritis& Rheumatology shows that monitoring patients' blood levels of hydroxychloroquine can predict their clotting risk. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 6, 2021 Category: International Medicine & Public Health Source Type: news

New research finds ginger counters certain autoimmune diseases in mice
(Michigan Medicine - University of Michigan) The main bioactive compound of ginger root lowers autoantibody production and helps halt disease progression in mice with antiphospholipid syndrome and lupus. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 6, 2021 Category: Biology Source Type: news

A new approach to study autoimmune diseases
This study, " Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis and rheumatoid arthritis, " is featured in the Jan. 6, 2021, edition ofScience Advances. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 6, 2021 Category: International Medicine & Public Health Source Type: news

FDA Expands Belimumab Indication to Adults With Nephritis FDA Expands Belimumab Indication to Adults With Nephritis
The approval is based on the BLISS-LN trial, in which belimumab when added to standard therapy increased response rates and prevented worsening of kidney disease in some patients with active lupus nephritis.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2020 Category: Consumer Health News Tags: Nephrology News Alert Source Type: news

FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
Approval builds on nearly 10 years of experience in lupus LONDON, Dec. 17, 2020 -- (Healthcare Sales & Marketing Network) -- GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved BENLYSTA (belimumab) for t... Biopharmaceuticals, FDA GlaxoSmithKline, BENLYSTA, belimumab, lupus nephritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 17, 2020 Category: Pharmaceuticals Source Type: news

FDA Approves GSK ’s Benlysta as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
17 December 2020 --  GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved Benlysta (belimumab) for the treatment of adult patients with active lupus nephritis (LN) who are receiving standard... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 17, 2020 Category: Drugs & Pharmacology Source Type: news

High-Need, High-Cost Lupus Patients Described for First Time High-Need, High-Cost Lupus Patients Described for First Time
A small group of patients with SLE who have high costs and needs and frequent hospitalizations can be identified through a shared set of sociodemographic characteristics and risk.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - December 16, 2020 Category: Primary Care Tags: Rheumatology News Source Type: news

TTUHSC's Sutton receives grant to continue work on potential lupus treatment
(Texas Tech University Health Sciences Center) The Lupus Research Alliance recently named R. Bryan Sutton, Ph.D., a professor at the TTUHSC School of Medicine, as a recipient of a 2020 Lupus Mechanisms and Targets Award. The grant could provide Sutton up to $200,000 a year for up to three years to continue his research into mechanisms that could cause or contribute to lupus in hopes of developing novel biological targets and new medications to treat a rare form of the disease. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 3, 2020 Category: International Medicine & Public Health Source Type: news

Systemic Lupus Erythematosus Abstracts From ACR Convergence Systemic Lupus Erythematosus Abstracts From ACR Convergence
Dr Michele Petri highlights abstracts on systemic lupus erythematosus from ACR 2020, including the effects of hydroxychloroquine on QTc length and use of belimumab and obinutuzumab on renal outcomes.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2020 Category: Consumer Health News Tags: None ReCAP Source Type: news

Slow Taper off Antimalarial Avoids Lupus Flare During Remission Slow Taper off Antimalarial Avoids Lupus Flare During Remission
Slowly tapering off – or remaining on – antimalarial medications can help prevent disease flare in patients with systemic lupus erythematosus who've achieved clinical remission for at least a year.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 30, 2020 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

Does an Autoimmune Disorder Affect My Covid-19 Risks?
Patients with conditions like lupus and rheumatoid arthritis, who may take immune suppressing drugs, do not appear to be at greatly increased risk from coronavirus. (Source: NYT Health)
Source: NYT Health - November 18, 2020 Category: Consumer Health News Authors: Mikkael A. Sekeres, M.D. Tags: Coronavirus (2019-nCoV) Autoimmune Diseases Immune System Rheumatoid Arthritis Lupus Erythematosus Hygiene and Cleanliness Content Type: Service Source Type: news

DDT COA #000130: Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in Cutaneous Lupus Erythematosus
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 12, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Lupus-Specific Predictors for CVD Described in Black Patients Lupus-Specific Predictors for CVD Described in Black Patients
Black patients with systemic lupus erythematosus (SLE) are known to have significantly elevated risk for stroke and ischemic heart disease, compared with non-Black patients with SLE.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 8, 2020 Category: Internal Medicine Tags: Rheumatology News Source Type: news

Coronavirus: Destructive 'autoantibodies' develop in some survivors
So-called 'autoantibodies' are similar to the autoimmune responses seen in diseases like lupus, some forms of hepatitis and rheumatoid arthritis, Emory University research suggests. (Source: the Mail online | Health)
Source: the Mail online | Health - October 29, 2020 Category: Consumer Health News Source Type: news

Some Covid survivors have antibodies that attack the body, not the virus
The findings carry important implications for treatment: Using existing tests that can detect autoantibodies, doctors could identify patients who might benefit from treatments used for lupus and rheumatoid arthritis. There is no cure for these diseases, but some treatments decrease the frequency and severity of flare-ups. (Source: The Economic Times)
Source: The Economic Times - October 28, 2020 Category: Consumer Health News Source Type: news

Some Covid Survivors Have Antibodies That Attack the Body, not Virus
New research found ‘autoantibodies’ similar to those in lupus and rheumatoid arthritis patients. But patients may also benefit from treatments for those autoimmune diseases. (Source: NYT Health)
Source: NYT Health - October 27, 2020 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Coronavirus (2019-nCoV) Immune System Research Chronic Condition (Health) Autoimmune Diseases Lupus Erythematosus Antibodies DNA (Deoxyribonucleic Acid) RNA (Ribonucleic Acid) Rheumatoid Arthritis your-feed-science your-feed-health Source Type: news

What Causes Joint Pain?
DiscussionMusculoskeletal problems are common problems in pediatric practice with up to 15% of acute care visits being for this problem. Joint pain is a common concern for families but the differential diagnosis is extensive and needs thoughtful consideration. History is a key to discerning the potential diagnosis but also in guiding the physical examination and laboratory examination. Family history especially for systemic diseases should be considered. On physical examination all joints should be examined include sacroiliac and temporomandibular joints. Is this arthritis or arthralgia? Distinction between inflammatory...
Source: PediatricEducation.org - October 26, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Update on Antimalarials and Systemic Lupus Erythematosus Update on Antimalarials and Systemic Lupus Erythematosus
A new review provides an update on recent evidence regarding the use of antimalarials in systemic lupus erythematosus.Current Opinion in Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 22, 2020 Category: Rheumatology Tags: Rheumatology Journal Article Source Type: news

Immune cell activation in severe COVID-19 resembles lupus
(Emory Health Sciences) In severe cases of COVID-19, activation patterns of B cells resemble those seen in systemic lupus erythematosus, an autoimmune disease. Emory researchers want to see how far that resemblance extends. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 9, 2020 Category: Infectious Diseases Source Type: news

Physical activity and sleep in adults with arthritis
(Wiley) A new study published in Arthritis Care& Research has examined patterns of 24-hour physical activity and sleep among patients with rheumatoid arthritis, lupus, and knee osteoarthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 7, 2020 Category: International Medicine & Public Health Source Type: news

Lupus symptoms: What is lupus, what are the signs?
LUPUS is an inflammatory condition that can be fatal. What are the signs and symptoms? (Source: Daily Express - Health)
Source: Daily Express - Health - October 5, 2020 Category: Consumer Health News Source Type: news

President Trump ’s COVID-19 Treatment Is Already Unique. Here’s What Doctors May Do Next
Just a few hours after revealing that he tested positive for COVID-19, U.S. President Donald Trump on Friday was helicoptered to Walter Reed Army Hospital, where he will be hospitalized for at least a few days “out of an abundance of caution,” the White House says; the First Lady, Melania Trump, has also tested positive. How the President of the United States is treated for COVID-19 will likely be very different from how the 7 million-plus other Americans who have contracted the disease were taken care of, at least in some ways. To start, before Trump was hospitalized, his physician Sean Conley revealed that th...
Source: TIME: Health - October 3, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news